Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking

BACKGROUND: Estimates of the risk of developing Crohn's disease (CD) can be made using DNA testing for mutations in the NOD2 (CARD15) gene, family history, and smoking status. Smoking doubles the risk of CD, a risk that is reduced by stopping. CD therefore serves as a timely and novel paradigm...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitwell, Sophia CL, Mathew, Christopher G, Lewis, Cathryn M, Forbes, Alastair, Watts, Sally, Sanderson, Jeremy, Hollands, Gareth J, Prevost, A Toby, Armstrong, David, Kinmonth, Ann Louise, Sutton, Stephen, Marteau, Theresa M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036624/
https://www.ncbi.nlm.nih.gov/pubmed/21247480
http://dx.doi.org/10.1186/1471-2458-11-44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036624/
https://www.ncbi.nlm.nih.gov/pubmed/21247480
http://dx.doi.org/10.1186/1471-2458-11-44

Ejemplares similares